By sharing your front-line perspectives on how antimicrobial resistance is impacting your ability to care for patients, you can make a big difference by raising awareness about the need to address growing resistance and the lack of antimicrobial research and development.

IDSA is working to address drug resistance and the dwindling antimicrobial research and development pipeline on multiple fronts.

Submit your abstracts now for IDWeek 2012, the first-ever combined meeting of IDSA, HIVMA, the Society for Healthcare Epidemiology of America (SHEA), and the Pediatric Infectious Diseases Society (PIDS), Oct. 17–21, 2012, in San Diego. The deadline is May 11.

This month: Studies investigating linezolid versus dose-optimized vancomycin for MRSA nosocomial pneumonia; CMV infection in transplant recipients and the incidence of antiviral resistance; anti-NMDAR encephalitis and the California Encephalitis Project; reversion of positive QuantiFERON-TB results to negative in low-risk HIV-infected patients; and PFC exposure and childhood antibody response.

• The first-ever combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct.17-21, 2012, in San Diego. Learn more online by reading the new FAQs section!
• Abstract submission closes May 11, 2012.

Renew Your IDSA Membership!
Due now!

Medical Scholars Program Deadline
March 1, 2012

Joint Research Awards Deadline
March 15, 2012

IDSA Society Awards Deadline
April 2, 2012

Advancement to Fellow Deadline
April 2, 2012

SHEA Spring 2012: Advancing Healthcare Epidemiology and Antimicrobial Stewardship
April 13-16, 2012 – Jacksonville, FL

International AIDS Society AIDS 2012
July 22-27, 2012 – Washington, D.C.

• HIVMA is a local scientific partner for the conference.